Product information

From Health Canada

Current status:

Approved

Current status date:

2023-02-06

Product name:

NALOXONE HYDROCHLORIDE INJECTION, USP

Description:

MULTIDOSE VIAL

DIN:

02534975 Electronic product monograph is not available

Company:

EUGIA PHARMA INC.
3700 Steeles Avenue West, Suite 402
Woodbridge
Ontario
Canada L4L 8K8

Class:

Human

Dosage form(s):

Solution

Route(s) of administration:

Intramuscular ,  Intravenous ,  Subcutaneous

Number of active ingredient(s):

1

Schedule(s):

Prescription

 

American Hospital Formulary Service (AHFS): See footnote 3

28:10.00 

Anatomical Therapeutic Chemical (ATC): See footnote 4

V03AB15 NALOXONE

Active ingredient group (AIG) number:See footnote5

0108981002

List of active ingredient(s)
Active ingredient(s) Strength
NALOXONE HYDROCHLORIDE 4 MG / 10 ML
Version 4.0.2
Date modified: